Compare HLLY & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLLY | BVS |
|---|---|---|
| Founded | 1903 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.4M | 508.4M |
| IPO Year | N/A | 2021 |
| Metric | HLLY | BVS |
|---|---|---|
| Price | $4.23 | $7.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $4.43 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 906.1K | 277.3K |
| Earning Date | 11-07-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $598,132,000.00 | $563,829,000.00 |
| Revenue This Year | $1.75 | N/A |
| Revenue Next Year | $5.07 | $7.11 |
| P/E Ratio | ★ N/A | $48.57 |
| Revenue Growth | N/A | ★ 1.58 |
| 52 Week Low | $1.60 | $5.81 |
| 52 Week High | $4.43 | $11.25 |
| Indicator | HLLY | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 53.73 |
| Support Level | $4.05 | $7.26 |
| Resistance Level | $4.31 | $7.71 |
| Average True Range (ATR) | 0.14 | 0.27 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 65.08 | 54.43 |
Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.